Mr. Wang Shanpu, Chairman of Modern Biological Group, delivered a wonderful summary of the work in 2024. Looking, we have made remarkable achievements in the journey of life and health, striving forward without fear of challenges. This year, we have taken innovation and technology as the force to promote the development of life and health, and our brand influence has become stronger and stronger, our team collaboration has become closer, and all tasks have been steadily. Looking to the future, facing the complex and changing industry environment, we need to stick to our original intention and strive for progress. Standing on the new starting point 2025, we will embrace new challenges and create a new glorious chapter together!

Avian leukemia is still an important disease affecting the poultry industry in some countries. Due to differences in breeding level, biosecurity measures and purification consciousness, the disease is still prevalent in chicken flocks in some areas to varying degrees, causing economic losses to the local poultry industry. The avian leukemia ELISA group-specific antigen detection kit is mainly used for disease diagnosis, epidemic monitoring, breeding flock purification, vaccine effect evaluation, etc Operational advantages: constant incubation temperature, reduced detection errors; detachable reaction plate, convenient operation, reduced waste.

Laipson will continue to deepen domestic and foreign cooperation and exchanges, taking it as its mission to promote the rapid and sustainable development of the global industry, and committed to providing mature products and high-quality services to ensure life health and food safety!